Editorial
doi: 10.1089/ard.1995.5.113.
Toward a broad-based antisense technology
- PMID: 7580114
- DOI: 10.1089/ard.1995.5.113
Item in Clipboard
Editorial
Toward a broad-based antisense technology
Antisense Res Dev.
1995 Summer.
No abstract available
Similar articles
-
Harnessing the power of antisense technology for combination chemotherapy.J Natl Cancer Inst. 1997 Jan 15;89(2):107-8. doi: 10.1093/jnci/89.2.107. J Natl Cancer Inst. 1997. PMID: 8998173 No abstract available.
-
Pharmacology of Antisense Drugs.Annu Rev Pharmacol Toxicol. 2017 Jan 6;57:81-105. doi: 10.1146/annurev-pharmtox-010716-104846. Epub 2016 Oct 10. Annu Rev Pharmacol Toxicol. 2017. PMID: 27732800 Review.
-
[Antisense oligonucleotides: a new therapeutic approach].Pathol Biol (Paris). 1998 May;46(5):347-54. Pathol Biol (Paris). 1998. PMID: 9769897 Review. French.
-
The disposition (ADME) of antisense oligonucleotides.Curr Opin Mol Ther. 2000 Jun;2(3):253-7. Curr Opin Mol Ther. 2000. PMID: 11249618 Review.
-
Peptide-oligonucleotide hybrids in antisense therapy.Mini Rev Med Chem. 2005 Jan;5(1):41-55. doi: 10.2174/1389557053402846. Mini Rev Med Chem. 2005. PMID: 15638791 Review.
Cited by
-
A cytosine analog that confers enhanced potency to antisense oligonucleotides.Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3513-8. doi: 10.1073/pnas.96.7.3513. Proc Natl Acad Sci U S A. 1999. PMID: 10097067 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources